There is cooperation. Jule Watch cooperated with Wuhan Tongji Hospital back in 2018 to carry out the project and research about the AIM project.The AIM project is China's first research on early warning for health big data life research based on wearable devices and artificial intelligence algorithms.
Scientists have found that blood pressure-specific changes are a major reference for the prediction of cardiovascular disease. However, under the current diagnosis and treatment model, in the treatment of cardiovascular disease, the lack of pre-hospital data, post-hospital can not be sustained follow-up, for the patient can neither predict the judgment of the risk of the relevant diseases, nor ensure the effect of healing treatment, and once the onset of re-emergence of the disease, the patient's life will be threatened.
Jule Science and Technology and Wuhan Tongji Hospital, in response to this situation, started the research and project of AIM program with an eye on smart health and smart medical care under the call of the State Council related documents. The project is based on wearable devices to develop a new program of artificial intelligence treatment. It creates a new model of pre-hospital monitoring data, providing reference during consultation, and post-hospital continuous monitoring to assist doctors in continuous treatment.
The AIM model is based on the continuous sign data collected by Jura Watch for patients with cardiovascular diseases, combined with the basic risk assessment and synthesized medication and other information, a recursive model is proposed. When there are abnormal signals in the monitoring that seriously exceed the model, patients can be reminded to seek timely medical treatment and shorten the time to be sent to the hospital after the onset of the disease. At the same time, Tongji Hospital doctors will make corresponding diagnosis and treatment countermeasures based on the data to shorten the judgment time of the patient's condition. After the healing process, the AIM program will continue to track the patient's data, and the corresponding doctors in Tongji will see the patient's data in the exclusive client, and use it as the basis for further observation or guidance on medication.
At present, the user database of Jura Tech in the AIM project has been connected with the database of Wuhan Tongji Hospital, and the related clinical experiments are being carried out orderly in some departments, and the results are beginning to show. The following picture is a display of the results, you can see the patients wearing Joule watches for data monitoring and recording when receiving treatment.